1. Speak, read, and understand English or Spanish and is willing and able to provide written informed consent on an IRB-approved form prior to the initiation of any study procedures; 
2. Healthy, premenopausal female age 18-47; 
3. History of menstrual events that occur in regular cycles 
4. Agreement not to attempt to become pregnant 
5. Agrees to use double-barrier contraception during the study and for 30 days after discontinuation of study medication. Acceptable double-barrier methods are: male condom with spermicide; male condom with diaphragm; diaphragm containing spermicide plus additional intra-vaginal spermicide; 
6. Has a negative pregnancy test at the Screening visit. An exception for the pregnancy test requirement will be granted for subjects reporting surgical sterilization in medical history 
7. Normal laboratory values or clinically insignificant findings at screening as determined by the Investigator; 
8. Subject is willing to remain in the clinic overnight for PK assessment on Days 0 and 8 
9. Ability to complete the study procedures in compliance with the protocol. 

NCT02141061_inc_T11
Condition
Healthy
NCT02141061_inc_T12
Condition
premenopausal
NCT02141061_inc_T13
Person
female
NCT02141061_inc_T14
Person
age
NCT02141061_inc_T15
Value
18-47
NCT02141061_inc_T16
Condition
menstrual events that occur in regular cycles
NCT02141061_inc_T17
Observation
History
NCT02141061_inc_T24
Measurement
pregnancy test
NCT02141061_inc_T25
Value
negative
NCT02141061_inc_T26
Temporal
at the Screening visit
NCT02141061_inc_T27
Reference_point
Screening visit
NCT02141061_inc_T30
Condition
Normal laboratory values
NCT02141061_inc_T31
Value
Normal
NCT02141061_inc_T32
Procedure
laboratory
NCT02141061_inc_T33
Measurement
laboratory
NCT02141061_inc_T34
Qualifier
clinically insignificant
NCT02141061_inc_T36
Condition
findings
NCT02141061_inc_T37
Temporal
at screening
NCT02141061_inc_T38
Reference_point
screening